The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
A safe lithium mimetic for bipolar disorder
Open accessAbstract
Lithium is the most effective mood stabilizer for the treatment of bipolar disorder, but it is toxic at only twice the therapeutic dosage and has many undesirable side effects. It is likely that a small molecule could be found with lithium-like efficacy but without toxicity through target-based drug discovery; however, therapeutic target of lithium remains equivocal. Inositol monophosphatase is a possible target but no bioavailable inhibitors exist. Here we report that the antioxidant ebselen inhibits inositol monophosphatase and induces lithium-like effects on mouse behaviour, which are reversed with inositol, consistent with a mechanism involving inhibition of inositol recycling. Ebselen is part of the National Institutes of Health Clinical Collection, a chemical library of bioavailable drugs considered clinically safe but without proven use. Therefore, ebselen represents a lithium mimetic with the potential both to validate inositol monophosphatase inhibition as a treatment for bipolar disorder and to serve as a treatment itself. Lithium is commonly used to treat bipolar disorder, but it exerts side effects at doses close to the therapeutic range. Singh and colleagues screen a collection of clinical compounds and find that ebselen induces lithium-like effects on mouse models of bipolar disorder by inhibiting inositol monophosphatase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Self-citationAnimal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
Nogueira, C. W., Zeni, G., & Rocha, J. B. T. (2004) · Chemical Reviews · doi:10.1021/cr0406559 · Cited by 1,926
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Drug-target residence time and its implications for lead optimization
Copeland, R. A., Pompliano, D. L., & Meek, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2082 · Cited by 1,464
LITHIUM SALTS IN THE TREATMENT OF PSYCHOTIC EXCITEMENT
Cade, J. F. J. (1949) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1949.tb36912.x · Cited by 1,463
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Studying noncovalent protein complexes by electrospray ionization mass spectrometry
Loo, J. A. (1997) · Mass Spectrometry Reviews · doi:10.1002/(sici)1098-2787(1997)16:1<1::aid-mas1>3.0.co;2-l · Cited by 1,182
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Lithium salts in the treatment of psychotic excitement
Cade, J. F. J. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.1999.06241.x · Cited by 1,150
Copeland, R. A. (2005) · PubMed · Cited by 1,092
Neural and developmental actions of lithium: A unifying hypothesis
Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,014
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Large-scale prediction and testing of drug activity on side-effect targets
Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., et al. (2012) · Nature · doi:10.1038/nature11159 · Cited by 881
Lithium toxicity profile: a systematic review and meta-analysis
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61516-x · Cited by 877
Baum, A. E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B., Schulze, T. G., Cichon, S., Rietschel, M., Nöthen, M. M., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002012 · Cited by 700
A common mechanism of action for three mood-stabilizing drugs
Williams, R. S. B., Cheng, L., Mudge, A. W., & Harwood, A. J. (2002) · Nature · doi:10.1038/417292a · Cited by 618
Ebselen in Acute Ischemic Stroke: A Placebo-Controlled, Double-blind Clinical Trial
Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T., & Yasuhara, H. (1998) · Stroke · doi:10.1161/01.str.29.1.12 · Cited by 610
Lithium toxicity profi le: a systematic review and meta-analysis
McKnight, R. F., Budge, K., Ba, S., Goodwin, G. M., Geddes, J. R., & Adida, M. (2012) · Cited by 544
Reengineering Translational Science: The Time Is Right
Collins, F. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002747 · Cited by 479
Molecular actions of Ebselen—an antiinflammatory antioxidant
Schewe, T. (1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)00003-j · Cited by 428
Quantifying the global cellular thiol–disulfide status
Hansen, R. E., Roth, D., & Winther, J. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812149106 · Cited by 424
Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001862 · Cited by 401
NIH Molecular Libraries Initiative
Austin, C. P., Brady, L. S., Insel, T. R., & Collins, F. S. (2004) · Science · doi:10.1126/science.1105511 · Cited by 348
Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
Barf, T., & Kaptein, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003203 · Cited by 331
Frantz, S. (2005) · Nature · doi:10.1038/437942a · Cited by 322
Sarma, B. K., & Mugesh, G. (2008) · Chemistry – A European Journal · doi:10.1002/chem.200801258 · Cited by 221
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study
Zarate, C. A., Singh, J. B., Carlson, P. J., Quiroz, J., Jolkovsky, L., Luckenbaugh, D. A., & Manji, H. K. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00530.x · Cited by 208
Quiroz, J. A. (2004) · Molecular Interventions · doi:10.1124/mi.4.5.6 · Cited by 206
Ebselen Protects Both Gray and White Matter in a Rodent Model of Focal Cerebral Ischemia
Imai, H., Masayasu, H., Dewar, D., Graham, D. I., & Macrae, I. M. (2001) · Stroke · doi:10.1161/hs0901.095725 · Cited by 177
Validating GSK3 as an in vivo target of lithium action
O'Brien, W. T., & Klein, P. S. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371133 · Cited by 157
Dextroamphetamine-induced arousal in human subjects as a model for mania
Jacobs, D. H., & Silverstone, T. (1986) · Psychological Medicine · doi:10.1017/s0033291700009132 · Cited by 152
The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics
O’Donnell, K. C., & Gould, T. D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.002 · Cited by 137
The BALANCE investigators and collaborators, Geddes, J. R., Goodwin, G. M., Rendell, J., Jm, A., Cipriani, A., Ostacher, M. J., Morriss, R. K., Alder, N. C., & Juszczak, E. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.4.foc488 · Cited by 134
Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
Li, X., Frye, M. A., & Shelton, R. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.198 · Cited by 131
Screening for the potential of a drug candidate to cause idiosyncratic drug reactions
Uetrecht, J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02816-2 · Cited by 125
Mood-stabilizing drugs: mechanisms of action
Schloesser, R. J., Martinowich, K., & Manji, H. K. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.009 · Cited by 122
Haenen, G. R. M. M., de Rooij, B. M., Vermeulen, N. P. E., & Bast, A. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10816-x · Cited by 114
Inositol monophosphatase — a putative target for Li+ in the treatment of bipolar disorder
Atack, J. R., Broughton, H. B., & Pollack, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93926-o · Cited by 107
McAllister, G., Whiting, P. J., Hammond, E. A., Knowles, M. R., Atack, J. R., Bailey, F. J., Maigetter, R. Z., & RAGAN, C. I. (1992) · Biochemical Journal · doi:10.1042/bj2840749 · Cited by 102
Conn, P. J., & Roth, B. L. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301638 · Cited by 87
Posser, T., Kaster, M. P., Baraúna, S. C., Rocha, J. B. T., Rodrigues, A. L. S., & Leal, R. B. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.055 · Cited by 86
Insel, T. R., Sahakian, B. J., Voon, V., Nye, J. S., Brown, V. J., Altevogt, B. M., Bullmore, E. T., Goodwin, G. M., Howard, R. J., Kupfer, D. J., et al. (2012) · Nature · doi:10.1038/483269a · Cited by 70
IMPA1 is Essential for Embryonic Development and Lithium-Like Pilocarpine Sensitivity
Cryns, K., Shamir, A., Acker, N. V., Levi, I., Daneels, G., Goris, I., Bouwknecht, J. A., Andries, L. J., Kass, S. U., Agam, G., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301431 · Cited by 68
The BALANCE trial – Authors' reply
Geddes, J. R., Rendell, J., Alder, N. C., & Goodwin, G. M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60570-3 · Cited by 63
Belmaker, R. H., Bersudsky, Y., Agam, G., Joseph Levine, M. D., & Kofman, O. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.47 · Cited by 63
Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?
Friston, K. J., Sharpley, A. L., Solomon, R. A., et al. (1989) · Psychopharmacology · doi:10.1007/bf00442020 · Cited by 58
Knockout mice in understanding the mechanism of action of lithium
Agam, G., Bersudsky, Y., Berry, G. T., Moechars, D., Lavi-Avnon, Y., & Belmaker, R. H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371121 · Cited by 50
Kofman, O., & Belmaker, R. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90155-5 · Cited by 38
Inositol monophosphatase inhibitors—Lithium mimetics?
Atack, J. R. (1997) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199703)17:2<215::aid-med3>3.0.co;2-2 · Cited by 34
Effect of Treatment and Withdrawal from Chronic Lithium in Rats on Stimulant-Induced Responses
Lerer, B., Globus, M., Brik, E., Hamburger, R., & Belmaker, R. H. (2008) · Neuropsychobiology · doi:10.1159/000118046 · Cited by 31
Where will new neuroscience therapies come from?
Schoepp, D. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3559 · Cited by 22
APT drug R&D: the right active ingredient in the right presentation for the right therapeutic use
Cavalla, D. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2981 · Cited by 22
Singh, N., Halliday, A. C., Knight, M., Lack, N. A., Lowe, E. D., & Churchill, G. C. (2012) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309112035191 · Cited by 14
Self-citationSchwab, M. E., & Buchli, A. D. (2012) · Nature · doi:10.1038/483267a · Cited by 10
Dolgin, E. (2012) · Nature Medicine · doi:10.1038/nm0212-190 · Cited by 4
Cited by
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2223-y · Cited by 4,358
Geddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848
The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 753
Can you teach old drugs new tricks?
Nosengo, N. (2016) · Nature · doi:10.1038/534314a · Cited by 729
Phenotypic screens as a renewed approach for drug discovery
Zheng, W., Thorne, N., & McKew, J. C. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.001 · Cited by 423
Metadata
- Authors
- Singh, N., Halliday, A. C., Thomas, J. M., Kuznetsova, O. V., Baldwin, R., Woon, E. C. Y., Aley, P. K., Antoniadou, I., Sharp, T., Vasudevan, S. R., & Churchill, G. C.
- Venue
- Nature Communications
- Published
- 2013-01-08
- Volume
- 4
- Issue
- 1
- Pages
- 1332-1332
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2010061463
- Cited by
- 258
- References
- 59
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.